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Abstract
Background: Exposures to high doses of irradiation, to chemotherapy, benzene, petroleum
products, paints, embalming fluids, ethylene oxide, herbicides, pesticides, and smoking have been
associated with an increased risk of acute myelogenous leukemia (AML). Although there in no
epidemiological evidence of relation between X-ray developer, fixer and replenisher liquids and
AML, these included glutaraldehyde which has weakly associated with lymphocytic leukemia in rats
and hydroquinone has been increasingly implicated in producing leukemia, causing DNA and
chromosomal damage, inhibits topo-isomerase II, alter hematopoiesis and inhibit apoptosis of
neoplastic cells.
Case presentation: Two white females (A and B) hired in 1985 as medical radiation technologists
in a primary care center, in Greece. In July 2001, woman A, 38-years-old, was diagnosed as having
acute monocytic leukaemia (FAB M5). The patient did not respond to therapy and died threeweeks
later. In August 2001, woman B, 35-year-old, was diagnosed with acute promyelocytic leukaemia
(FAB M3). Since discharge, she is in continuous complete remission. Both women were non
smokers without any medical history. Shortly after these incidents official inspectors and experts
inspected workplace, examined equipment, archives of repairs, notes, interviewed and monitored
employees. They concluded that shielding was inadequate for balcony's door but personal
monitoring did not show any exceeding of TLV of 20 mSv yearly and cytogenetics analysis did not
reveal findings considered to be characteristics of ionizing exposure. Equipment for developing
photos had a long list of repairs, mainly leakages of liquids and increases of temperature. On several
occasions the floor has been flooded especially during 1987–1993 and 1997–2001. Inspection
confirmed a complete lack of ventilation and many spoiled medical x-ray films. Employees reported
that an "osmic" level was continuously evident and frequently developed symptoms of respiratory
irritation and dizziness.
Conclusion: The findings support the hypothesis that the specific AML cases might have originated
from exposure to chemicals, especially hydroquinone and/or glutaraldehyde. The report also
emphasises the crucial role of inspection of facilities and enforcement of compliance with
regulations in order to prevent similar incidents.
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Background
Most cases of acute myelogenous leukemia (AML) arise
with no clear cause. Several factors have been associated
with an increased risk of disease including exposures to
high doses of irradiation, to chemical benzene, to chemo-
therapy etc. Anticancer drugs, mainly alkylating agents
and topoisomerase II inhibitors, are the leading cause of
treatment-associated AML. Inherited diseases with exces-
sive chromatin fragility, e.g., Fanconi anemia, ataxia tel-
angiectasia and, Kostmann syndrome, are associated with
an increased risk of AML. Syndromes with somatic cell
chromosome aneuploidy, e.g., Down (chromosome 21
trisomy), Klinefelter (XXY and variants), and Patau (chro-
mosome 13 trisomy), are also associated with an
increased risk of AML. In addition to benzene, exposure to
petroleum products, paints, embalming fluids, ethylene
oxide, herbicides, pesticides, and smoking are associated
with an increased risk of AML.
Increased risk of leukaemia has been described among
nursing and healthcare workers [1]. Radiologists and radi-
ologic technologists comprise occupational groups
exposed to low doses of ionizing radiation. To date, there
is no clear evidence of increased leukaemia mortality in
medical radiation workers exposed to current levels of
radiation doses (below 20 mSv). Data from cohort studies
of radiologic technologists provided statistically signifi-
cant evidence of excess leukemia risk only among workers
who were employed before 1950 eventhough recent
cohorts of radiologic workers have not been followed up
as long as the earlier ones [2-7].
Hydroquinone has been used in industry as a corrosion
inhibitor, a fixative (graphics industry), substance of pol-
ystyrene manufacture, and in rubber production. Also it
has been used for decades as a skin lightening agent but
since January 2001 its use in cosmetics has been banned
due to effects such as leukoderma-en-confetti or occupa-
tional vitiligo and exogenous ochronosis and concerns
have raised regarding its carcinogenic potential [8,9].
Most of the evidence stems from research on benzene tox-
icity, which appears to arise via its metabolite hydroqui-
none. It causing DNA and chromosomal damage found in
leukemia, inhibits topo-isomerase II, and alters hemat-
opoiesis and clonal selection [10-14]. Additionally, hyd-
roquinone is related to the inhibition of the apoptosis of
neoplastic cells [15-17]. It is also hypothesized that back-
ground sources of hydroquinone and associated adducts,
stem mainly from dietary ingestion, play a causal role in
producing some forms of de novo leukemia in the general
population [18]. On the other hand we have not up to
now strong evidence and support of carcinogenicity from
epidemiological studies with HQ and myelotoxicity asso-
ciated with human exposure to HQ [19].
Glutaraldehyde is weakly associated with large granular
lymphocytic leukemia in rats and has greater toxicity than
formaldehyde [20].
Incidence of AML in white females in USA has risen to 3.6
per 100,000 people in 2001, the highest incidence of the
period 1975–2003. Even though AML incidence increases
dramatically among people who are over 40, a 20.5% of
AML patients were diagnosed under age 44 during 1998–
2002 in the United States compared to approximately
10.2% of patients of all types of cancers [21].
This study reports two cases of AML in workers potentially
exposed to several chemicals and ionizing radiation.
Case presentation
Two women (referred to as A and B in the text) were
employed by Social Security Institute, the largest primary
health care provider in Greece. They were hired in 1985,
as X-ray assistants (radiographers) in a regional primary
care center in a city of 40,000 inhabitants. Permanent per-
sonnel include also another two women, who were also
employed by the regional center and hired at 1985 and
1993 without further referring in our report.
Patient A
She was born at 1962; she was non smoker without any
medical history. On the afternoon shift of 13 July 2001,
she passed out and asked and received for a sick leave. Five
days later, (18th July 2001), she was admitted to haema-
tology clinic of a big private hospital of Athens and diag-
nosed with acute myelogenous leukaemia. Bone marrow
aspirate showed 65% blasts mainly (80%) with mono-
cytic morphology. Flow cytometric immunophenotyping
demonstrated expression of HLA-DR+/CD64+, CD36+/
CD116+, CD14+/-, cCD68+, CD33++, CD13+/-, CD4+
and non expression of CD34, CD79a, CD20, CD10 and,
CD3. Cytogenetic analysis showed a normal female kary-
otype of 46XX. These results were consistent with a diag-
nosis of acute monocytic leukemia (FAB M5). The patient
did not respond to therapy and died three weeks later (6th
August 2001).
Patient B
She was born at 1965, she was non smoker and from her
medical history she had only a laparoscopic cholocystec-
tomy in 1997. Her mother suffered from diabetes mellitus
and coronary artery disease. She had never exposed to any
other known factor predisposing for haematological dis-
order. In 13th August 2001 she was admitted to Division
of Hematology of University hospital of Athens, where
she was hospitalized for eight months. Bone marrow aspi-
rate showed 99% blasts. Blasts were of medium size with
loose chromatin, thin cytoplasmatic granulations peroxi-
dase-positive. Cytogenetics on the bone marrow sampleJournal of Occupational Medicine and Toxicology 2006, 1:19 http://www.occup-med.com/content/1/1/19
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showed a karyotype of 46, XX, t(15:17)(q22:q12). These
results were consistent with the diagnosis of AML with
t(15:17)(q22:q12), acute promyelocytic leukaemia
according to the World Health Organisation classification
(FAB M3). Since discharge from hospital on 23/3/2002 is
in continuous complete remission.
Occupational history and autopsies
Official inspectors from Ministry of Labour and medical
and technical experts inspected workplace shortly after the
incident (9–11/2001) and they examined equipment,
archives of repairs, notes, and personal monitoring of
employees [Additional files 1, 2, 3]. In addition employ-
ees were interviewed and based on that information it was
concluded that:
The X-ray department of the Primary Care Center was first
licensed in July 1986. The license should be renewed every
5 years. However, in the event that there is no radiologist
in charge, as was the case during the periods 1987 to May
1994 and between April 2000 and August 2001, the
license for the operation of the department should have
been revoked. In July 1994 it was necessary to renew the
license. However, further regulations stipulated shielding
of the balcony door of the X-ray room and regular tuning
or adjustment of the lamp current. In October 1995, the
same preconditions were deemed necessary by the Greek
Committee of Atomic Energy. The most important prob-
lem during the study period (1985–2001) seemed to be
the absence of shield protection on the balcony door in
the X-ray room. The female employees reported that due
to a foul stench they often had to leave the X-ray room for
the balcony. It is a matter of contention whether the
employees were carrying the dosimeters at all times. If not
the exposure would then be higher than the recorded one.
In any case, the recorded exposure was ascertained from
monthly records the period 1993–2001, never exceeded
the safety limit levels of 20mSv prescribed by legislation.
The X-ray apparatus presented many faults in 1989 and
for the following 2 years has presented problems with
respect to high voltage readings and overheating. As a
result, about 7500 films have been destroyed. The lamp
current was adjusted only once in 1994. However, follow-
ing a thorough check in June 1999 it was found that it was
not possible to achieve high current intensities and ade-
quate high voltages. It was suspected that current and volt-
age outputs were lower than the set values at high currents
and voltages. The apparatus was used at the maximum
dose rate of 4.5 R/min with a permissible upper limit
equal to 5 R/min. In June 1999, it was also found that the
filter in the X-ray lamp was 1.5 mm instead of 2.1 mm Al
as required by legislation. It was replaced by a 3 mm Al fil-
ter. On the other hand, the apparatus could not achieve
the correct currents and voltages and the maximum dose
rate was lower than the expected.
Many serious problems were also associated with the
development room. These included seepage from the
tank, leakage from the waste faucet and an overheated
working environment. From 1987 to 1992 over 20 prob-
lems associated with welding the tanks, short circuits, lack
of thermostat control, seepage of waste and illegal dis-
posal of wastes from fixing silver salts were recorded. Dur-
ing the period 1987–1990, all liquid wastes were collected
in jerry cans, which often over spilled on the floor. The
result was continues leakages of development and fixing
liquids. This in conjunction with high temperatures and
an inadequate exhaust system resulted in an unbearable
stench and symptoms such as headaches, irritation of the
eyes and the upper respiratory track and on occasion dys-
pnoea. The illegal disposal of wastes from fixing and
developing salts compounded the problem.
The development apparatus (1985–1993) was replaced in
1993. However, new problems appeared in 1995, necessi-
tating frequent alterations, which continued until 2001.
In conjunction with a complete lack of proper ventilation,
the stench and the symptoms presented by the employees
persisted. All the above problems evident from the state
and condition of the developing room, official notes and
interviews are well documented. They now constitute
proof of high exposure of the employees to toxic sub-
stances found in developing liquids. The chemical com-
position of the liquids is summarized in Table 1.
Synopsis of aforementioned basic information
Three employees in an x-ray department worked under
similar conditions for 16 years. Two of them were diag-
nosed in the period of a month as having acute myeloid
leukaemia (AML). AML standardized incidence rate in
women is approximately 1.5 cases per 100000 person-
years in the age group of 35–39 years (14). In the small
town, where the incident took place, the expected annual
incidence of AML was less than 0.06 in the age group of
35–39 years. Consequently, the possibility of the reported
incident to be random was extremely low. Since both
employees had no medical history or exposure to any
other known causal factor of leukaemia it was hypothe-
sised that acute myelogenous leukaemia had an occupa-
tional origin.
Experts' reports showed that: 1) the X-ray department had
inadequate shielding at balcony's door 2) the X-ray appa-
ratus could not achieve the correct currents and voltages
and the maximum dose rate was lower than the expected,
it presented many faults in 1989 and sporadically later,
and the filter in the X-ray lamp was 1.5 mm instead of 2.1
mm Al. It was replaced by a 3 mm Al filter in June 1999 3)Journal of Occupational Medicine and Toxicology 2006, 1:19 http://www.occup-med.com/content/1/1/19
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personal monitoring did not show any exceeding of TLV
of 20 mSv yearly in film badges 4) extended cytogenetics
analysis did reveal neither dicentric or polycentric chro-
mosomes nor interstitial deletions, centric fragments or
inversions considered to be characteristics of ionizing
exposure 5) equipment for developing x-rays films had a
long list of repairs, mainly leakages of liquids and
increases of temperature. Many times floor has been
flooded especially during 1987–1993 and 1997–2001.
Floor had brown stains form effluent chemicals [Figure 1];
6) in the development apparatus room there was com-
plete lack of ventilation and many spoiled medical x-ray
films 7) employees reported that an "osmic" level was
continuously evident and frequently developed symp-
toms of headache, respiratory irritation and dizziness.
These reports confirmed from notes of employees protest-
ing about working conditions and in addition there was
not any medical file of employees and health monitoring.
Data collected from various sources like autopsies in
workplace and inspections of equipment and archives of
official notes; employees' interviews; film badges etc. pro-
vided strong evidence that employees were exposed con-
stantly to harmful X-ray developer, fixer and replenisher
liquids over a 16-years period. These substances included
hydroquinone, glutaraldeyde, acetic acid, 1-phenyl-3-
pyrazolidone, sodium sulphite, sulphuric acid and other
chemicals. Glutaraldehyde has weakly associated with
large granular lymphocytic leukemia in rats while hydro-
quinone (HQ) has been increasingly implicated in pro-
ducing leukemia. In addition sulfuric acid mist correlated
with lung, nasal and larynx cancers. Even though it is well
documented that HQ in the effluent from photo process-
ing and wastewaters had been present for a long period,
HQ should not volatilize easily because of its water solu-
bility, very low vapour pressure, and high vapour density.
HQ, in an open body of water, would be expected to both
biodegrades and photo degrades. In the presence of mois-
ture and ambient level of oxygen, hydroquinone undergo
oxidation to 1,4-benzoquinone, which is more likely to
volatilize because of its higher vapour pressure [22]. High
temperatures had enhanced this confirming by brown
stains near central heating mode. So it is anticipated that
exposure of employees via inhalation include both hydro-
quinone and 1,4-benzoquinone. In addition exposure
through skin might be happened in a lesser extent.
There is always, a small possibility, for employees to be
exposed to radiation. This is limited to the hypothesis that
employees spent time in balcony, where shielding of the
door was not sufficient (adequate). This habit might con-
tribute to radiation exposure in case those employees did
not wear their film badges. In contrast was that extended
cytogenetics analysis did not reveal either dicentric or
polycentric chromosomes or interstitial deletions, centric
fragments or inversions considered to be characteristics of
ionizing exposure. Radiation and hydroquinone could
induce a chromosomal instability that may contribute to
AML development by increasing the number of genetic
lesions in hemopoietic cells. Recent research showed that
this effect could be induced by hydroquinone doses that
are not acutely stem cell toxic [23]. Preliminary findings
showed a synergistic effect of hydroquinone when com-
bined with ionizing radiation in terms of SCEs, and a pos-
sible synergistic effect when chromatid breaks are
analysed after G2-phase irradiation [24].
Radiographers or medical radiation technologists are
potentially exposed to multiple chemicals in processing
and developing radiographs, which can cause irritation of
the eyes and upper airways, asthma-like symptoms
(cough, wheeze or dyspnea), headaches, dizziness,
fatigue, etc. "Darkroom disease" (DRD) has been used to
describe unexplained multiple symptoms attributed by
radiographers to their work environment. Exposure to
chemicals may occur through leaks and from mists and
vapors from the processor, from film and through pour-
ing chemicals. Inadequate ventilation, frequently detect-
ing odor of X-ray processing chemicals and cleaning up
spills were highly associated with most of the symptoms.
It is possible that acetic acid, sulphur dioxide, or other vol-
atile chemicals such as glutaraldehyde might account for
irritant and/or odorrelated nasal, eye, and other irritant
effects [25-31].
Hydroquinone is odourless but alkaline solutions readily
form 1,4-benzoquinone which has odour threshold of 0.1
ppm. Glutaraldehyde has an odor threshold of 0.04 ppm
(0.16 mg/m3) in air, acetic acid has an odor threshold
ranging from 2.5 to 250 mg/m3, and that for sulphur diox-
ide ranges from 1.18 to 12.5 mg/m3 but measured levels
of radiographers' exposure to glutaraldehyde, acetic acid,
and sulfur dioxide were not associated with reported
odor. Because measured exposures to glutaraldehyde were
considerably lower than this, glutaraldehyde is less likely
to have been detected by the study subjects.
Surveys have shown that x-ray workers are exposed to glu-
taraldehyde levels between 1–10 µg/m3, and for acetic
acid, and sulphur dioxide less than 0.1 mg/m3 [29-33].
Concentrations of other chemical constituents as well as
their interactions are not well known. Under routine con-
ditions, Teschke et al., found that exposures to X-ray
processing chemicals have been shown to be well below
the levels permitted by most regulatory agencies [30]. Air-
borne concentrations of glutaraldehyde measured after a
spill of 2% activated solution were found to greatly exceed
exposure limits [34].Journal of Occupational Medicine and Toxicology 2006, 1:19 http://www.occup-med.com/content/1/1/19
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Stains from processing chemicals (photo of development room) Figure 1
Stains from processing chemicals (photo of development room).Journal of Occupational Medicine and Toxicology 2006, 1:19 http://www.occup-med.com/content/1/1/19
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Conclusion
To our knowledge, the cases presented here are the first
reported cases of AML probably related to exposure to X-
ray developer, fixer and, replenisher liquids. Hydroqui-
none and in a lesser degree glutaraldehhyde are hypothe-
sised to be the causal factors. Perhaps combined exposure
to other chemicals or to low dose x-ray might have played
a role.
In this facility an average of 300 films per week processed
and the consumption of developer (part A-hydroquinone
6.2%) was estimated around 7.5 lt. The complete lack of
direct local exhaust ventilation of the processing machine
(and insufficient general room ventilation), the excessive
radiographic film processor heating, the high room tem-
perature (30–35°C), and the irregular or no use of silver
recovery unit could increase volatility of chemicals includ-
ing hydroquinone. In addition, personnel besides regular
duties (taking X-rays, waiting in the processing area, refill-
ing chemicals and observing film) had cleaned up spills
several times without using any personal protective equip-
ment (gloves and goggles). Based on these circumstances,
we anticipated levels of exposure well above permitted
levels (Table 1). In addition few tasks with potential for
skin-wetting exposures have frequently taken place (e.g.,
cleaning the processor, refilling chemicals or cleaning
spills) so some dermal exposure might contributed to
higher exposure levels.
For hydroquinone, only recently, has been defined an
occupational exposure limit in Greece (PD 90/7.5.1999)
in addition to the fact that any kind of environmental
monitoring is highly unexpected in regional public health
sector. The latter emphasises the need for preventive
actions such as information for employees about the pos-
sible toxic effects of chemicals and education on proper
handling, storing and, disposal. In our case it seems that
adequate ventilation might have been sufficient for per-
sonal protection. For most of the chemical factors as
clearly was indicated in material safety data sheets
(MSDS) for exposure control and personal protection it
was recommended to ventilate work area, with ten (10) or
more air changes per hour. Under normal operating con-
ditions and with adequate ventilation and proper storage
the exposure would be minimized. The failure to protect
the employees seemed to be due to failure to comply with
existing occupational safety and health rules. This also
emphasises the significance of inspection of facilities and
enforcement of compliance with regulations in order to
prevent similar incidents.
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Table 1: Composition of X-ray developer, fixer and, replenisher liquids (TLVs based on Presidential Directive 90/1999)
INGREDIENTS CAS NUMBER Wt% TLV-TWA* TLV- STEL*
Acetic Acid 64-19-7 3–66 25 mg/m3
10 ppm
37 mg/m3
15 ppm
Aluminum Sulfate 10043-01-3 9,5
Ammonium Thiosulfate 7783-18-8 40–60
Boric acid 10043-35-3 1–5
Diethylene Glycol 111-46-6 1–5
Glutaraldehyde 111-30-8 30–40 0.8 mg/m3 0.8 mg/m3
Hydroquinone 123-31-9 6,2 2 mg/m3 4 mg/m3
1-phenyl-3-Pyrazolidinone 92-43-3 6,7
Potassium Sulfite & 
metabisulfite
10117-38-1 & 16731-55-8 5–10
Sodium Acetate 127-09-3 1–5
Sodium Bromate 7789-38-0 0,5-1
Sodium Sulfite 7757-83-7 5–10
Sodium Tetraborate 1330-43-4 5–10 10 mg/m3
Sulfuric acid 7664-93-9 4,6 1 mg/m3
Water 7732-18-5 20–95
*TLV-TWA: Threshold Limit Value-Time Weighted Average (8-hour workshift)
TLV-STEL: Threshold Limit Value-Short Term Exposure Limit (15-minute)Journal of Occupational Medicine and Toxicology 2006, 1:19 http://www.occup-med.com/content/1/1/19
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